A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting Conditions
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
To compare the rate and extent of absorption of griseofulvin from a test formulation of
Griseofulvin 125 mg/5 mL Suspension versus the reference Grifulvin V® 125 mg/5 mL Suspension
under fasting conditions.